Jobs filters
POSTDOCTORAL FELLOW - HEMATOLOGICAL MALIGNANCIES TRANSLATIONAL SCIENCES - 10027995
Monrovia, CACity of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases.
Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a wholly owned subsidiary, was launched in 2019 and is dedicated to serving employers and their health care partners by providing access to City of Hope’s exceptional cancer expertise.
A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.
Join the forefront of groundbreaking research at the Beckman Research Institute of City of Hope, where we're changing lives and making a real difference in the fight against cancer, diabetes, and other life-threatening illnesses. Our dedicated and compassionate faculty and staff are driven by a common mission: Contribute to innovative approaches in predicting, preventing, and curing diseases, shaping the future of medicine through cutting-edge research.
We are looking for a highly motivated and creative Postdoctoral Fellow to work within the laboratories of Dr. Flavia Pichiorri, Professor in the Department of Hematological Malignancies Translational Science, and Briskin Myeloma Center.
The key research area for this group focuses on:
1) Identification of novel anti-myeloma therapeutic interventions including bispecific antibodies and oncolytic viruses
2) Understanding the role myeloma high risk feature for driving mechanisms of resistance
3) Immune correlative studies in patients enrolled in Phase 1 and Phase 2 trials.
The group conducts the most forefront science and is highly productive with publications in high-impact journals in the past five years, Blood (2024, 2021), Leukemia (2019), Blood advances (2022), J Hematol Oncol. (2024). Dr. Pichiorri 's research program is supported by several NIH (R01s). City of Hope is in the pleasant city of Los Angeles of Southern California.
As a successful candidate, you will:
· Devise, plan, document and advance basic science and translational projects in the relevant research areas
· Collect data for grant applications and prepare manuscripts for publication
· Work in close collaboration with other team members and external partners from academia and industry, including presentation of progress internally or externally
· Train and supervise technical staff
Your qualifications should include:
· A Ph.D. or M.D. with a strong background and profound knowledge in the field of immunology, cancer biology and oncolytic viruses.
· Multiple first author publication in high-impact journals
· Previous experience in working with animal models
· Literature knowledge of one of the three research areas mentioned above
City of Hope is an equal opportunity employer. To learn more about our commitment to diversity, equity and inclusion, please click here.
To learn more about our Comprehensive Benefits, please CLICK HERE.